Compare 10X Genomics Inc (TXG) vs UDR Inc. Common Stock (UDR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs UDR Inc. Common Stock — how do they compare? 10X Genomics Inc trades at $71.65 (market cap $9.35B), while UDR Inc. Common Stock trades at $33.9 (market cap $10.93B). The key difference: UDR Inc. Common Stock is the larger of the two by market cap, and UDR Inc. Common Stock pays a 5.12% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold 10X Genomics Inc for 91 Days and UDR Inc. Common Stock for 0 Days on average.
| TXG | UDR | |
|---|---|---|
Market Cap | $9.35B | $10.93B |
Volume | 4,039,449 | 2,607,837 |
Sector | Health | Real Estate |
52-Week High | $97.74 | $41.24 |
52-Week Low | $11.83 | $33.27 |
Typical Hold Time | 91 Days | 0 Days |
Enterprise Value | $8.88B | $16.96B |
Dividend Yield | — | 5.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TXG trades at $73.10, down 2.78% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $642.82M in 2025 but a net loss of $43.54M, though recent quarters show earnings beats. Analyst consensus is mixed with a $83.30 price target. Positive news includes Atera shipments and a patent victory, but profitability remains a challenge.
The outlook hinges on Atera's commercial success driving future revenue growth and margin improvement. Risks include persistent losses, competitive pressures, and execution delays. Upside potential exists if new platforms gain traction, but investors should weigh high valuation multiples against ongoing unprofitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About UDR Inc. Common Stock
UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →
